Conflict of interest declaration: Bastian von Tresckow
New declaration of interest submissions
Updated on: 9 March 2022
Roles in: Haematology Group
1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the Group/Unit?
a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
Yes
- AbbVie, AstraZeneca, Kite-Gilead, Merck Sharp & Dohme, Takeda, and Novartis
b) Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events?
Yes
- AstraZeneca, Novartis, Roche Pharma AG, Takeda, and Merck Sharp & Dohme
c) Fees for organising education?
No
d) Grants and contracts?
Yes
- Novartis (Inst), Merck Sharp & Dohme (Inst), and Takeda (Inst)
e) Funds for a member of staff?
No
f) Fees for consulting?
Yes
- Allogene, BMS/Celgene, Cerus, Incyte, Miltenyi, Novartis, Pentixafarm, Roche, Amgen, Pfizer, Takeda, Merck Sharp & Dohme, and Gilead Kite
g) Royalty or licences payments?
No
h) Payment for expert testimony?
No
i) Payment for a fellowship?
No
j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
No
k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No
2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No
3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No
4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the Group/Unit?
No
5. Do you have any other competing interests (financial or non-financial)?
Yes
- Member of the following societies: ASH, DGHO, EHA, GLA, GHSG, DGIM, WSG